Clinical course of Graves' orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational

Derya Tepe1, Duygu Deligozoglu1, Ceyda Baskan2

  • 1Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Türkiye.

Insights

Childhood Graves' orbitopathy (GO) is typically mild and inactive, showing rare progression. Despite improvements in thyroid autoimmunity, ocular symptoms remained stable, indicating a generally benign course.

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Pediatrics

Background:

  • Graves' orbitopathy (GO) in children is often milder than in adults, but data on its clinical course and relation to thyroid autoimmunity are limited.
  • Understanding the characteristics of pediatric GO is crucial for effective management and patient outcomes.

Purpose of the Study:

  • To determine the frequency and clinical features of GO in children with newly diagnosed hyperthyroidism.
  • To assess short-term changes in ocular findings and their relationship with thyroid autoimmunity markers during follow-up.

Main Methods:

  • A prospective observational study included 24 children with hyperthyroidism.
  • Ophthalmologic examinations followed 2021 EUGOGO criteria, with disease activity assessed by Clinical Activity Score (CAS).
  • Thyroid function tests and autoantibodies were measured at baseline and 6 months, with statistical analysis of associations.

Main Results:

  • Most pediatric patients (83.3%) presented with mild GO, and none showed active orbitopathy (CAS <3).
  • Ocular findings (Hertel measurements) remained stable over 6 months, despite significant reductions in thyroid autoantibodies.
  • A positive correlation was found between baseline Hertel values and thyrotropin receptor antibody levels.

Conclusions:

  • Pediatric Graves' orbitopathy is generally mild and inactive with rare short-term progression.
  • Ocular findings in children with hyperthyroidism tend to be stable, even with improving thyroid autoimmunity.
  • These findings support a benign course for childhood GO, highlighting the need for thorough ophthalmologic evaluation at diagnosis.
Abstract

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...